Melanoma: Multimedia

Researchers Caution Against Combining Two Drugs for Treating Metastatic Melanoma

Researchers have found that combining ipilimumab (YervoyTM) and vemurafenib (Zelboraf®) can cause side effects for patients with metastatic melanoma.

Runtime: 02:00 minutes Published: 04/03/2013 - 2:40 PM
Advances in Skin Cancer Treatment

Medical experts from Memorial Sloan Kettering discuss new strategies for preventing, diagnosing, and treating skin cancer.

Runtime: 84:00 minutes Published: 05/08/2012 - 3:56 PM
Advances in the Treatment of Melanoma

Medical oncologists Paul Chapman and Jedd Wolchok describe two studies of promising new therapies for advanced melanoma.

Runtime: 5:00 minutes Published: 06/01/2011 - 12:00 AM
Skin Cancer: Latest Developments in Detection, Diagnosis, and Treatment

A study has shown that a new drug for melanoma decreased the risk of death by 63 percent for people with advanced disease. The drug, an oral medical called vemurafenib, works by targeting and silencing a particular gene mutation associated with melanoma. Another study revealed that the FDA-approved ipilimumab (Yervoy™) bolsters the body’s immune system in fighting advanced melanoma. This therapy could extend life when combined with traditional chemotherapy.

Published: 04/14/2009 - 12:00 AM